What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continents

Background
The foot and ankle are frequently affected in rheumatic and musculoskeletal diseases (RMDs), yet there is a lack of high-quality evidence to determine the effectiveness of treatments. Outcomes in research are often inconsistently measured, impeding evidence synthesis. Additionally, clinical decisions are based on research outcomes, but these are not always regarded as important by people with RMDs. This study aimed to determine domains of importance to people with RMDs who have experienced foot and ankle disorders, and aid in developing a standardised core outcome set (COS) to address these issues.
Methods
Participants from four continents (Europe, Africa, Australia, North America) were recruited to semi-structured interviews through clinical departments and electronic mailing lists. Analysis was conducted using a mixed deductive/inductive approach to the framework method. Patient research partners co-produced the interview schedule and recruitment materials, and co-interpreted results.
Results
Fifty-six participants (age range 27 to 76 years; 66 % female), with foot and ankle disorders in a variety of RMDs (including inflammatory arthritis, osteoarthritis, crystal arthropathies, connective tissue diseases), were interviewed. Sixteen domains were described by participants: pain, physical function, fatigue, deformity, skin and nail health, swelling, temperature, numbness, poor circulation, cramping, activities/participation, footwear impact, psychological impact, sleep, healthcare utilisation and personal expenses. Most domains were considered important to participants regardless of RMD or geographic location.
Conclusions
Foot and ankle disorders have far-reaching consequences for people with RMDs. This large qualitative study provides a foundation for achieving international consensus on a core outcome set for foot and ankle disorders in RMDs, to improve the quality of evidence demonstrating effectiveness of treatments.

Contributors

Lara S. Chapman, Caroline A. Flurey, Pamela Richards, Anthony C. Redmond, Eiman Soliman, Abdelhfeez Moshrif, Lucy Malone, Christopher Joyce, John B. Arnold, Yvonne M. Golightly, Catherine Hofstetter, Philip S. Helliwell, Hylton B. Menz, Marian T. Hannan, Nazibur Rahman, Beverley J. Shea, Toby O. Smith, Heidi J. Siddle

Publication

Journal: Seminars in Arthritis and Rheumatism
Volume: 72
Issue:
Pages: -
Year: 2025
DOI: 10.1016/j.semarthrit.2025.152671

Further Study Information

Current Stage: Completed
Date:
Funding source(s): Lara Chapman is funded by a Health Education England (HEE)/Na tional Institute for Health Research (NIHR) Clinical Doctoral Research Fellowship (ID NIHR302173). Professor Heidi Siddle is funded by a HEE/NIHR Senior Clinical Lectureship (ID ICA-SCL-2018–04-ST2–004). Prof Anthony Redmond is a NIHR Senior Investigator. The views expressed in this publication are those of the authors and not necessarily those of NIHR, University of Leeds NHS or the UK Department of Health and Social Care.


Health Area

Disease Category: Rheumatology

Disease Name: Foot and ankle disorders

Target Population

Age Range: 18 - 100

Sex: Either

Nature of Intervention: Any

Stakeholders Involved

Study Type

- Patient perspectives

Method(s)

- Interview

Participants from four continents (Europe, Africa, Australia, North America) were recruited to semi-structured interviews through clinical departments and electronic mailing lists. Analysis was conducted using a mixed deductive/inductive approach to the framework method. Patient research partners co-produced the interview schedule and recruitment materials, and co-interpreted results.